Phibro Animal Shares Owned By Institutions vs. EBITDA

PAHC Stock  USD 24.14  0.40  1.68%   
Taking into consideration Phibro Animal's profitability measurements, Phibro Animal Health may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Phibro Animal's ability to earn profits and add value for shareholders. At present, Phibro Animal's Sales General And Administrative To Revenue is projected to increase slightly based on the last few years of reporting. The current year's Operating Cash Flow Sales Ratio is expected to grow to 0.09, whereas Price To Sales Ratio is forecasted to decline to 0.64. At present, Phibro Animal's Income Tax Expense is projected to increase significantly based on the last few years of reporting. The current year's Income Quality is expected to grow to 38.07, whereas Accumulated Other Comprehensive Income is projected to grow to (117.4 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.220.3077
Way Down
Pretty Stable
Operating Profit Margin0.05760.0524
Significantly Up
Slightly volatile
Pretax Profit Margin0.01020.0107
Notably Down
Very volatile
For Phibro Animal profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Phibro Animal to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Phibro Animal Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Phibro Animal's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Phibro Animal Health over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.94)
Dividend Share
0.48
Earnings Share
0.43
Revenue Per Share
25.843
Quarterly Revenue Growth
0.126
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Phibro Animal Health EBITDA vs. Shares Owned By Institutions Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Phibro Animal's current stock value. Our valuation model uses many indicators to compare Phibro Animal value to that of its competitors to determine the firm's financial worth.
Phibro Animal Health is considered to be number one stock in shares owned by institutions category among its peers. It also is considered to be number one stock in ebitda category among its peers totaling about  850,903  of EBITDA per Shares Owned By Institutions. At present, Phibro Animal's EBITDA is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Phibro Animal's earnings, one of the primary drivers of an investment's value.

Phibro Animal's Earnings Breakdown by Geography

Phibro EBITDA vs. Shares Owned By Institutions

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Phibro Animal

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
99.43 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Phibro Animal

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
84.61 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Phibro EBITDA Comparison

Phibro Animal is currently under evaluation in ebitda category among its peers.

Phibro Animal Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Phibro Animal, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Phibro Animal will eventually generate negative long term returns. The profitability progress is the general direction of Phibro Animal's change in net profit over the period of time. It can combine multiple indicators of Phibro Animal, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-123.5 M-117.4 M
Operating Income53.3 M51.9 M
Income Before Tax10.9 M10.4 M
Total Other Income Expense Net-42.4 M-40.3 M
Net Income Applicable To Common Shares37.5 M42.5 M
Net Income2.4 M2.3 M
Income Tax Expense8.5 M9.8 M
Net Income From Continuing Ops2.4 M2.3 M
Non Operating Income Net Other-2.8 M-2.7 M
Interest Income4.5 M2.8 M
Net Interest Income-18.5 M-19.5 M
Change To Netincome-11.6 M-11 M
Net Income Per Share 0.06  0.06 
Income Quality 36.26  38.07 
Net Income Per E B T 0.22  0.21 

Phibro Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Phibro Animal. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Phibro Animal position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Phibro Animal's important profitability drivers and their relationship over time.

Use Phibro Animal in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Phibro Animal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phibro Animal will appreciate offsetting losses from the drop in the long position's value.

Phibro Animal Pair Trading

Phibro Animal Health Pair Trading Analysis

The ability to find closely correlated positions to Phibro Animal could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Phibro Animal when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Phibro Animal - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Phibro Animal Health to buy it.
The correlation of Phibro Animal is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Phibro Animal moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Phibro Animal Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Phibro Animal can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Phibro Animal position

In addition to having Phibro Animal in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Latest Gainers Thematic Idea Now

Latest Gainers
Latest Gainers Theme
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Gainers theme has 200 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Gainers Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:
To fully project Phibro Animal's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Phibro Animal Health at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Phibro Animal's income statement, its balance sheet, and the statement of cash flows.
Potential Phibro Animal investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Phibro Animal investors may work on each financial statement separately, they are all related. The changes in Phibro Animal's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Phibro Animal's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.